Bluesight announces the acquisition of Protenus, the provider of a healthcare compliance analytics platform. The acquisition aims to strengthen Bluesight’s drug diversion platform and add critical patient privacy monitoring capabilities to better protect healthcare organizations and the communities they serve. Protenus leverages artificial intelligence capabilities to provide healthcare organizations with scalable risk-reduction solutions to drive safe, high-quality patient outcomes. Bringing together Bluesight’s intelligence to power pharmacy operations and Protenus’ expertise in compliance and risk management creates a platform offering innovative solutions for compliance, medication safety, and operational efficiency.